Cargando…
miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease
OBJECTIVE: Non-alcoholic fatty liver disease (NAFLD) is a complex pathology in which several dysfunctions, including alterations in metabolic pathways, mitochondrial functionality and unbalanced lipid import/export, lead to lipid accumulation and progression to inflammation and fibrosis. The enzyme...
Autores principales: | Fernández-Tussy, Pablo, Fernández-Ramos, David, Lopitz-Otsoa, Fernando, Simón, Jorge, Barbier-Torres, Lucía, Gomez-Santos, Beatriz, Nuñez-Garcia, Maitane, Azkargorta, Mikel, Gutiérrez-de Juan, Virginia, Serrano-Macia, Marina, Rodríguez-Agudo, Rubén, Iruzubieta, Paula, Anguita, Juan, Castro, Rui E., Champagne, Devin, Rincón, Mercedes, Elortza, Felix, Arslanow, Anita, Krawczyk, Marcin, Lammert, Frank, Kirchmeyer, Mélanie, Behrmann, Iris, Crespo, Javier, Lu, Shelly C., Mato, José M., Varela-Rey, Marta, Aspichueta, Patricia, Delgado, Teresa C., Martínez-Chantar, María L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728756/ https://www.ncbi.nlm.nih.gov/pubmed/31668391 http://dx.doi.org/10.1016/j.molmet.2019.08.008 |
Ejemplares similares
-
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis
por: Fernández-Ramos, David, et al.
Publicado: (2018) -
TRAIL-producing NK cells contribute to liver injury and related fibrogenesis in the context of GNMT deficiency
por: Fernández-Álvarez, Sara, et al.
Publicado: (2014) -
Methionine Cycle Rewiring by Targeting miR-873-5p Modulates Ammonia Metabolism to Protect the Liver from Acetaminophen
por: Rodríguez-Agudo, Rubén, et al.
Publicado: (2022) -
The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury
por: Barbier-Torres, Lucía, et al.
Publicado: (2017) -
Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): Impact of the PNPLA3
(
I148M
) risk allele
por: Kirchmeyer, Mélanie, et al.
Publicado: (2023)